Search results
Buying the Dip in These 3 Undervalued Dividend Stocks
Motley Fool via Yahoo Finance· 2 days agoWe have seen a stock pullback here in April, and three of these high-quality dividend paying stocks...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 11 hours agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 2 days agoGet a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March...
AbbVie buyout Cerevel marks trial win for Parkinson’s drug
Seeking Alpha· 7 days agoAbbVie's (ABBV) buyout target, Cerevel Therapeutics (CERE), announced positive data for its...
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 days agoAbbVie ABBV will report first-quarter 2024 results on Apr 26, before market open. In the last...
Abbvie Inc (ABBV) Shares Up Despite Recent Market Volatility – News Heater
NewsHeater· 3 days agoThe stock price of Abbvie Inc (NYSE: ABBV) has surged by 1.06 when compared to previous closing price of 164.66, but the company has seen a 2.54% gain in its stock price over ...
Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
Zacks via Yahoo Finance· 5 days agoAbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings...
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
Investor's Business Daily· 5 days agoAbbVie stock has slumped 9% off its record high in March and is facing increasingly steep...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks via Yahoo Finance· 12 hours agoThe following day, i.e., on Apr 26, AbbVie ABBV is slated to release its first-quarter results...
AbbVie Inc. (NYSE:ABBV) to Post Q1 2024 Earnings of $2.21 Per Share, William Blair Forecasts
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at William Blair issued their Q1 2024 EPS estimates for AbbVie in a research note issued to investors ...